We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Need for Rapid Containment Measures to Drive Growth of Global COVID-19 Detection Kits Market

By LabMedica International staff writers
Posted on 30 May 2020
The growth of the global COVID-19 detection kits market will be driven by the responsiveness of countries to contain the spread of the coronavirus and advancements in healthcare facilities.

These are the latest findings of Transparency Market Research Pvt. More...
Ltd. (Albany, NY, USA), a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. The World Health Organization (WHO) has declared the coronavirus as a global health emergency, following an outbreak of cases in several parts of the world. Currently, more than 180 countries have reported cases of coronavirus among individuals of all age groups. The vulnerability of all groups of people to the virus has created panic among the masses. Therefore, it is important to ramp up manufacturing of COVID-19 detection kits. The value of the COVID-19 detection kits market is continuously rising on account of advancements in healthcare facilities

The healthcare industry has recalibrated its focus on fighting the pandemic. Countries such as Italy, the US, and Spain have been the worst-hit by the pandemic. Therefore, the use of COVID-19 detection kits in these regions has increased by leaps and bounds. As India ramps up its pace of testing, several companies have come to the fore of the healthcare industry. India has also received testing kits from South Korea, which is an important dynamic of market growth. The success of testing facilities in India has been a primary driver of demand within the global market.

Despite strict containment measures such as lockdowns and ban on public gathering, the risk of virus spread remains high. Several healthcare professionals and entities, including the WHO, recommend rapid testing as the foremost strategy to control the virus. Increased number of tests has helped countries in flattening the curve of the COVID-19 spread. Furthermore, testing has also helped governments and state authorities in contact tracing of affected individuals. Thus, the manufacturing of COVID-19 detection kits has assumed significant importance in various parts of the world. The presence of a seamless industry for COVID-19 testing will play a vital role in driving sales across the global market. The development of test kits that can deliver results in less than six hours will play a defining role in the growth of the global COVID-19 detection kits market.

Related Links:
Transparency Market Research Pvt. Ltd.


Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
Online QC Software
Acusera 24•7
Automated Coagulation Analyzer
Hemolumi H6
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Illustration of the new blood test, which uses a DNA chip to detect the tumor’s biological fingerprint (Photo courtesy of Tel Aviv University)

Blood Test on a Chip Offers Low-Cost Lung Cancer Detection Without DNA Sequencing

Lung cancer is the leading cause of cancer deaths worldwide, and screening often yields indeterminate results that prompt invasive workups. Computed tomography (CT) detects small nodules but can flag benign... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy

Liquid biopsy has expanded access to tumor genomics, but most blood-based assays rely on short, degraded fragments of cell-free circulating tumor DNA (ctDNA). Isolating intact circulating tumor cells from... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.